Welcome to Coulter Partners Global (English)

16 July 2020

Top hires for VC & PE portfolio companies Q2-2020

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Contract research organisation Eastern Europe
Chief Technology Officer Haematology products Netherlands
Chief Operating Officer Gene editing US
Chief Commercial Officer Digital health and wellbeing platform UK
Chief Development Officer Drug discovery Belgium
Managing Director US CDMO France
VP Finance Rare diseases Switzerland
VP Technical Operations Gene therapy US
Head of Discovery A.I. drug discovery UK
VP Regulatory Affairs Therapeutic platform US
SVP Manufacturing & Supply Chain Cell & gene therapy Finland
Head of CMC Gene editing technology US
General Counsel Immuno-oncology UK
Chair Vascular medical devices Netherlands

Newly opened projects include:

Function Focus area Location
CEO Immunology platform Germany
CEO Vaccines UK
CEO Orthopaedic products US
Chief Financial Officer Life science VC US
Chief Operating Officer Healthcare services Sweden
Head of DMPK Respiratory diseases UK
EVP Commercial Laboratory services Germany
Head of CMC Cell therapy Singapore
VP Client Engagement Dental services US
Director Business Operations China Speciality pharma Denmark
Chair Oncology diagnostics Europe
Associate Life science VC Netherlands


A new version of Coulter Partners is available.